JP2010504995A5 - - Google Patents

Download PDF

Info

Publication number
JP2010504995A5
JP2010504995A5 JP2009530554A JP2009530554A JP2010504995A5 JP 2010504995 A5 JP2010504995 A5 JP 2010504995A5 JP 2009530554 A JP2009530554 A JP 2009530554A JP 2009530554 A JP2009530554 A JP 2009530554A JP 2010504995 A5 JP2010504995 A5 JP 2010504995A5
Authority
JP
Japan
Prior art keywords
compound
effective amount
hydrogen
formula
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009530554A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010504995A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/079384 external-priority patent/WO2008039754A1/en
Publication of JP2010504995A publication Critical patent/JP2010504995A/ja
Publication of JP2010504995A5 publication Critical patent/JP2010504995A5/ja
Pending legal-status Critical Current

Links

JP2009530554A 2006-09-28 2007-09-25 2−メチレン−(20r,25s)−19,27−ジノル−(22e)−ビタミンd類縁体 Pending JP2010504995A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84880306P 2006-09-28 2006-09-28
PCT/US2007/079384 WO2008039754A1 (en) 2006-09-28 2007-09-25 2-methylene-(20r,25s)-19,27-dinor-(22e)-vitamin d analogs

Publications (2)

Publication Number Publication Date
JP2010504995A JP2010504995A (ja) 2010-02-18
JP2010504995A5 true JP2010504995A5 (enExample) 2010-10-21

Family

ID=38860081

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009530554A Pending JP2010504995A (ja) 2006-09-28 2007-09-25 2−メチレン−(20r,25s)−19,27−ジノル−(22e)−ビタミンd類縁体

Country Status (8)

Country Link
US (1) US7741314B2 (enExample)
EP (1) EP2069297A1 (enExample)
JP (1) JP2010504995A (enExample)
AU (1) AU2007300214A1 (enExample)
CA (1) CA2662992A1 (enExample)
MX (1) MX2009003241A (enExample)
NZ (1) NZ575111A (enExample)
WO (1) WO2008039754A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8193170B2 (en) * 2008-07-10 2012-06-05 Wisconsin Alumni Research Foundation 2-methylene-19,26-dinor-(20R,22E,25R)-vitamin D analogs
US8399439B2 (en) * 2008-07-10 2013-03-19 Wisconsin Alumni Research Foundation 2-methylene-19,26-dinor-(20S,22E,25R)-vitamin D analogs
EP2525799B1 (en) * 2009-10-02 2014-09-03 Wisconsin Alumni Research Foundation (20s,22e)-2-methylene-19-nor-22-ene-1alpha,25-dihydroxyvitamin d3 analogs
US20110237557A1 (en) * 2010-03-23 2011-09-29 Deluca Hector F Diastereomers of 2-methylene-19-nor-22-methyl-1alpha,25-dihydroxyvitamin d3
US8664206B2 (en) 2010-03-23 2014-03-04 Wisconsin Alumni Research Foundation Diastereomers of 2-methylene-19-nor-22-methyl-1α,25-dihydroxyvitamin D3
US8604009B2 (en) * 2010-03-23 2013-12-10 Wisconsin Alumni Research Foundation (20S)-2-methylene-19-nor-22-dimethyl-1α,25-dihydroxyvitamin D3 and (20R)-2-methylene-19-nor-22-dimethyl-1α,25-hydroxyvitamin D3
CA2824870C (en) * 2011-06-14 2018-08-14 Wisconsin Alumni Research Foundation 3-desoxy-2-methylene-19-nor-vitamin d analogs and their uses
WO2013059060A1 (en) * 2011-10-21 2013-04-25 Wisconson Alumni Research Foundation 2-methylene-vitamin d analogs and their uses

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486333A (en) * 1981-04-10 1984-12-04 Felix Sebba Preparation of biliquid foam compositions
US4666634A (en) * 1984-12-05 1987-05-19 Chugai Seiyaku Kabushiki Kaisha vitamin D3 derivatives having a substituent at 2-position
US5086191A (en) * 1991-05-28 1992-02-04 Wisconsin Alumni Research Foundation Intermediates for the synthesis of 19-nor vitamin D compounds
JP2898882B2 (ja) * 1993-04-05 1999-06-02 ウイスコンシン アラムナイ リサーチ フオンデーシヨン 2−位に置換基を有する19−ノル−ビタミンd3 化合物
US5945410A (en) * 1997-03-17 1999-08-31 Wisconsin Alumni Research Foundation 2-alkyl-19-nor-vitamin D compounds
US5843928A (en) * 1997-03-17 1998-12-01 Wisconsin Alumni Research Foundation 2-alkylidene-19-nor-vitamin D compounds
SI3146969T1 (en) * 1999-04-23 2018-08-31 Leo Pharma A/S Ointment for topical treatment of psoriasis
US6806262B2 (en) * 2000-05-31 2004-10-19 Wisconsin Alumni Research Foundation 2-ethyl and 2-ethylidene-19-nor-vitamin D compounds
EP1305946A1 (en) 2000-07-21 2003-05-02 Koninklijke Philips Electronics N.V. Method and system for determining a user profile
AU7544501A (en) * 2000-09-08 2002-03-22 Wisconsin Alumni Res Found 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications
US6627622B2 (en) * 2002-02-18 2003-09-30 Wisconsin Alumni Research Foundation (20S)-1α-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
US6566352B1 (en) * 2002-02-18 2003-05-20 Wisconsin Alumni Research Foudation 1 α-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses
GB0305332D0 (en) 2003-03-10 2003-04-09 Leuven K U Res & Dev Biological evaluation of novel vitamin D analogues
US20050009792A1 (en) 2003-07-08 2005-01-13 Deluca Hector F. (20S)-1alpha-hydroxy-2-methylene-19-nor-vitamin D3 and its uses
WO2005051323A2 (en) 2003-11-25 2005-06-09 Wisconsin Alumni Research Foundation Vitamin d analogs for obesity prevention and treatment
WO2006057884A2 (en) * 2004-11-22 2006-06-01 Wisconsin Alumni Research Foundation 2α-METHYL AND 2ß-METHYL ANALOGS OF 19,26,27-TRINOR-(20S)-1α-HYDROXYVITAMIN D3 AND THEIR USES
CA2597624C (en) * 2005-02-11 2012-08-14 Wisconsin Alumni Research Foundation 2-methylene-19-nor-(20s-24s)-1.alpha.,25-dihydroxyvitamin-d2
US7528122B2 (en) 2006-02-02 2009-05-05 Wisconsin Alumni Research Foundation Vitamin D analog—NEL, methods and uses thereof
NZ570814A (en) * 2006-04-06 2011-11-25 Wisconsin Alumni Res Found 2-methylene-1alpha-hydroxy-19,21-dinorvitamin D3 analogs and uses thereof

Similar Documents

Publication Publication Date Title
JP2010505739A5 (enExample)
JP2010504995A5 (enExample)
JP2009532458A5 (enExample)
JP2008520689A5 (enExample)
JP2008520703A5 (enExample)
JP2005529878A5 (enExample)
CA2420026A1 (en) 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications
JP2010504994A5 (enExample)
TWI598098B (zh) 脂質異常症治療劑
JP2007512376A5 (enExample)
JP2008520691A5 (enExample)
JP2004509853A5 (enExample)
Drucker et al. Glucagon-like peptide-1 (GLP-1) receptor agonists, obesity and psoriasis: diabetes meets dermatology
CA2588410A1 (en) 2-methylene-19-nor-1.alpha.-hydroxy-17-ene-homopregnacalciferol and its uses
CA2588415A1 (en) 2-methylene-19,26,27-trinor-(20s)-1-alpha-hydroxyvitamin d3 and its uses
JP2011527695A5 (enExample)
JP2011527699A5 (enExample)
JP2008520704A5 (enExample)
JP2009533483A5 (enExample)
JP2011527696A5 (enExample)
JP2008520690A5 (enExample)
JP2008530110A5 (enExample)
CA2597624A1 (en) 2-methylene-19-nor-(20s-24s)-1.alpha.,25-dihydroxyvitamin-d2
CA2531505A1 (en) (20s)-1.alpha.-hydroxy-2-methylene-19-nor-vitamin d3 and its uses
JP2008520709A5 (enExample)